Inventor
Yu-Sheng Chao
Inventor
Warren, NJ, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12NMicroorganisms or enzymes3%
C07CAcyclic or carbocyclic compounds1%
C07HSugars1%
C12YEnzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
9,926,298'Heterocyclic compounds and use thereof'20189,862,703'Heterocyclic compounds and use thereof'20189,827,228Opioid receptor modulators and use thereof20179,388,193'Dipicolylamine derivatives and their pharmaceutical uses'20169,255,072'Pyrazole compounds and thiazole compounds as protein kinases inhibitors'20169,006,252'Fused multicyclic compounds as protein kinase inhibitors'20158,962,845'Pyrazole compounds'20158,710,079'Quinoline compounds and their use for treating viral infection'20148,697,658'Glycoside compounds'20148,507,502'Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors'20138,486,959'Dibenzo[f,h]isoquinoline derivatives'20138,415,482'Proline derivatives'20138,354,442'Imidazol-4-one and imidazole-4-thione compounds'20138,198,284'Treatment of neurodegenerative disorders with thiourea compounds'20128,138,194'Fused bicyclic pyrimidine compounds as aurora kinase inhibitors'20128,058,427'Coumarin compounds and their use for treating cancer'20118,048,426'Extracts from Chlorella '20118,026,271'Formulations of indol-3-yl-2-oxoacetamide compounds'20118,022,096'Pyrrolidine derivatives'20117,985,763'Hepatitis C virus inhibitors'20117,939,523'Imidazolidinone and imidazolidinethione derivatives'20117,897,764'Thiourea derivatives'20117,834,046'Thiophene compounds'20107,803,799'Selenophene compounds'20107,705,024'Oxadiazole compounds'20107,687,504'Pyrrolidine compounds'20107,544,712'Treatment of coronavirus infection'20097,456,289'Anti-tumor compounds'20087,449,478'Indole compounds'20087,425,633'Pyrrolidine compounds'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2016Patents assigned to NAT HEALTH RESEARCH INSTITUTES (24)· patent assignee history
2008–2012Based in Warren, NJ, US· patent location history
2009–2010Based in Taipei, TW· patent location history
2011–2016Patents assigned to CHAO YU-SHENG (10)· patent assignee history
2011–2015Patents assigned to HSIEH HSING-PANG (5)· patent assignee history
2011–2015Based in Monmouth Junction, NJ, US· patent location history
2012–2016Patents assigned to HSU TSU-AN (4)· patent assignee history
2012–2015Patents assigned to COUMAR SELVARAJ MOHANE (3)· patent assignee history
2014–2018Based in New York, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NAT HEALTH RESEARCH INSTITUTES | 24 | 2008–2016 |
| CHAO YU-SHENGself | 10 | 2011–2016 |
| HSIEH HSING-PANG | 5 | 2011–2015 |
| HSU TSU-AN | 4 | 2012–2016 |
| COUMAR SELVARAJ MOHANE | 3 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Warren, New Jersey, US | 13 | 2008–2012 |
| New York, New York, US | 8 | 2014–2018 |
| Monmouth Junction, New Jersey, US | 7 | 2011–2015 |
| Taipei, TW | 2 | 2009–2010 |